During the last session, Compass Pathways Plc ADR (NASDAQ:CMPS)’s traded shares were 0.82 million, with the beta value of the company hitting 2.25. At the end of the trading day, the stock’s price was $4.16, reflecting an intraday gain of 0.48% or $0.02. The 52-week high for the CMPS share is $8.54, that puts it down -105.29 from that peak though still a striking 40.14% gain since the share price plummeted to a 52-week low of $2.49. The company’s market capitalization is $386.26M, and the average trade volume was 1.05 million shares over the past three months.
Compass Pathways Plc ADR (CMPS) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CMPS has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Compass Pathways Plc ADR (CMPS) registered a 0.48% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.48% in intraday trading to $4.16, hitting a weekly high. The stock’s 5-day price performance is -0.48%, and it has moved by 4.52% in 30 days. Based on these gigs, the overall price performance for the year is -44.09%.
The consensus price target of analysts on Wall Street is $23, which implies an increase of 81.91% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $23 and $23 respectively. As a result, CMPS is trading at a discount of -452.88% off the target high and -452.88% off the low.
While earnings are projected to return 33.15% in 2025, the next five years will return 17.08% per annum.
CMPS Dividends
Compass Pathways Plc ADR is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 3.67 million shares, is of CITADEL ADVISORS LLC’s that is approximately 5.3652% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $22.16 million.
Also, the Mutual Funds coming in first place with the largest holdings of Compass Pathways Plc ADR (CMPS) shares are ARK ETF Trust-ARK Genomic Revolution ETF and iShares Trust-iShares Biotechnology ETF . Data provided on Apr 30, 2025 indicates that ARK ETF Trust-ARK Genomic Revolution ETF owns about 1.66 shares. This amounts to just over 1.77 percent of the company’s overall shares, with a $6.9 million market value. The same data shows that the other fund manager holds slightly less at 404.65, or about 0.43% of the stock, which is worth about $1.68 million.
